Noble Continues Supplying Antimicrobial Technology for KCI

10/14/2013
Noble Biomaterials, Inc. renewed its relationship with KCI Manufacturing, as the antimicrobial technology partner for the company's V.A.C. GranuFoam Silver Dressing. Noble had previously been the technology provider, and this new agreement will continue that relationship for several years.

"Our vision is to be the premier provider of bacterial management solutions for health improvement applications," said Jeff Keane, CEO of Noble. "This continued partnership supports our mission to improve people's lives and helps us provide solutions that touch countless patients and their families every day."

Utilizing Noble's proprietary X-STATIC antimicrobial technology, the V.A.C.  GranuFoam Silver Dressing provides an effective barrier to bacterial penetration and may help reduce infection in millions of patients suffering from chronic, acute, sub-acute, traumatic, and dehisced wounds, partial thickness burns, ulcers, flaps and grafts. It was jointly designed and optimized for use with the KCI V.A.C.  Therapy System to deliver negative pressure to help heal patient wounds.

"KCI is a recognized global leader in advanced wound care technology," said Karin Mueller Recchione, vice president of marketing at Noble. "And our partnership allows us jointly to deliver the benefits of X-STATIC technology to patients worldwide."

V.A.C.  GranuFoam Silver Dressing allows the silver coated foam pores to come in direct contact with the wound, eliminating the need for additional silver dressing layers. X-STATIC technology provides 100 percent surface coverage even after sizing the dressing. 

It has been shown to inhibit in vitro growth of more than 150 types of microorganisms including common wound pathogens such as Staphylococcus aureus, Streptococcus pyogenes and Klebsiella pneumonia. In vitro studies have also shown it reduces the growth of antibiotic-resistant strains of bacteria including MRSA and VRE.
X
This ad will auto-close in 10 seconds